中超控股(002471.SZ):深圳鑫騰華所持6340萬股司法拍賣流拍
格隆匯11月4日丨中超控股(002471.SZ)公佈,公司披露了《關於公司股東所持部分公司股份被司法拍賣的提示性公告》,公司股東深圳市鑫騰華資產管理有限公司(“深圳鑫騰華”)持有的6340萬股公司股票於2019年11月02日10時起至2019年11月03日10時止(延時的除外)在阿里巴巴司法拍賣網絡平台上進行公開拍賣。根據阿里巴巴司法拍賣網絡平台頁面顯示,此次拍賣流拍。
截至本公告日,深圳鑫騰華持有公司股份約2.54億股,佔公司總股本的20%。深圳鑫騰華持有的公司股票全部處於司法凍結和輪候凍結狀態。上述司法拍賣的股份合計6340萬股,佔深圳鑫騰華目前所持公司股票25%,佔公司股份總數的5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.